Exagen Inc.

XGN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Revenue$17,244$17,202$15,498$13,655
% Growth0.2%11%13.5%
Cost of Goods Sold$7,169$6,807$6,375$5,178
Gross Profit$10,075$10,395$9,123$8,477
% Margin58.4%60.4%58.9%62.1%
R&D Expenses$1,730$1,483$1,284$1,656
G&A Expenses$0$0$0$9,804
SG&A Expenses$11,445$11,542$11,204$10,204
Sales & Mktg Exp.$0$0$0$400
Other Operating Expenses$0$0$0$0
Operating Expenses$13,175$13,025$12,488$11,860
Operating Income-$3,100-$2,630-$3,365-$3,383
% Margin-18%-15.3%-21.7%-24.8%
Other Income/Exp. Net-$3,986-$1,772-$387-$366
Pre-Tax Income-$7,086-$4,402-$3,752-$3,749
Tax Expense$1$37$0$12
Net Income-$7,087-$4,439-$3,752-$3,761
% Margin-41.1%-25.8%-24.2%-27.5%
EPS-0.31-0.21-0.2-0.2
% Growth-47.6%-5%0%
EPS Diluted-0.31-0.21-0.2-0.2
Weighted Avg Shares Out22,86121,08618,55718,203
Weighted Avg Shares Out Dil22,94021,08618,55718,203
Supplemental Information
Interest Income$0$85$158$197
Interest Expense$1,316$1,124$545$563
Depreciation & Amortization$466$466$440$415
EBITDA-$5,304-$2,812-$2,767-$2,771
% Margin-30.8%-16.3%-17.9%-20.3%